483 GlaxoSmithKline dba Human Genome Sciences Jan 2020

483 GlaxoSmithKline dba Human Genome Sciences Jan 2020

Amy Devlin FDA, Thuy Nguyen FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline dba Human Genome Sciences - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 29 Jan 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Jan 2020
  • Location: Rockville, United States
  • FEI: 3003782237
Add To Cart